Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.22 (
cdc2
)
8,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CDC37
, an essential gene in Saccharomyces cerevisiae, interacts genetically with multiple protein kinases and is required for production of
Cdc28p
/cyclin complexes through an unknown mechanism. We have identified mammalian p50Cdc37 as a protein kinase-targeting subunit of the molecular chaperone Hsp90. Previously, p50 was observed in complexes with pp60v-src and Raf-1, but its identity and function have remained elusive. In mouse fibroblasts, a primary target of Cdc37 is Cdk4. This kinase is activated by D-type cyclins and functions in passage through G1. In insect cells, Cdc37 is sufficient to target Hsp90 to Cdk4 and both in vitro and in vivo, Cdc37/Hsp90 associates preferentially with the fraction of Cdk4 not bound to D-type cyclins. Cdc37 is coexpressed with cyclin Dl in cells undergoing programmed proliferation in vivo, consistent with a positive role in cell cycle progression. Pharmacological inactivation of Cdc37/Hsp90 function decreases the half-life of newly synthesized Cdk4, indicating a role for Cdc37/Hsp90 in Cdk4 stabilization. This study suggests a general role for p50Cdc37 in signaling pathways dependent on intrinsically unstable protein kinases and reveals a previously unrecognized chaperone-dependent step in the production of Cdk4/cyclin D complexes.
...
PMID:Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. 866 33
CDC37
was originally identified as a Start gene in budding yeast and has been shown to be required for association of CDC28 with cyclins. The exact functional mechanism by which
CDC37
promotes this association, however, remains unknown. CDK4 is a
cyclin D-dependent kinase
that controls progression through G1 of the mammalian cell cycle. We have detected a specific association of CDK4 with the molecular chaperon HSP90 and a 44-kDa protein that we identify as mammalian
CDC37
. A physical interaction between
CDC37
and CDK4 suggests that
CDC37
may regulate the mammalian cell cycle through a direct effect on CDK4. Association of CDK4 with both
CDC37
and HSP90 may also imply a mechanistic link between the functions of
CDC37
and HSP90.
...
PMID:Physical interaction of mammalian CDC37 with CDK4. 870 9
Using the yeast two-hybrid system we have identified novel potential Cdk4 interacting proteins. Here we described the interaction of Cdk4 with a human homologue of the yeast Drosophila
CDC37
gene products. Cdc37 protein specifically interacts with Cdk4 and Cdk6, but not with Cdc2,
Cdk2
, Cdk3, Cdk5 and any of a number of cyclins tested. Cdc37 is not an inhibitor nor an activator of the Cdk4/cyclin D1 kinase, while it appears to facilitate complex assembly between Cdk4, and cyclin D1 in vitro. Cdc37 competes with p16 for binding to Cdk4, suggesting that p16 might exert part of its inhibitory function by affecting the formation of Cdk4/cyclin D1 complexes via Cdc37.
...
PMID:Interaction between Cdc37 and Cdk4 in human cells. 915 Mar 68
We have performed biochemical analyses of
cdk6
complexes in T cells. By gel filtration chromatography we observed at least three
cdk6
containing complexes in the cell, the most abundant eluting at 450 kDa and 50-70 kDa and a minor complex eluting at 170 kDa. Cyclin D was present in the minor 170 kDa complex which co-eluted with the peak of cdk associated in vitro Rb kinase activity. Analysis of proteins that co-immunoprecipitated with
cdk6
showed that the 450 kDa complex contained both Hsp90 and
CDC37
. The 50-70 kDa complex was made up of two moieties, a 66 kDa complex containing
cdk6
bound to p19INK4d and monomeric
cdk6
. The subcellular localisation of the
cdk6
complexes was analysed by preparing cytoplasmic and nuclear extracts. The 450 kDa complex was shown to be predominantly cytoplasmic, whereas the 170 kDa cyclin D/
cdk6
and the 50-70 kDa complexes were present in both nuclear and cytoplasmic compartments. When these same extracts were assayed for
cdk6
associated kinase activity, only the nuclear
cdk6
complexes were active. These data suggest that even though there are
cdk6
/cyclin D complexes detectable in both the cytoplasm and nucleus, only the
cdk6
that is in the nucleus is active.
...
PMID:Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells. 948 6